help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by di Clemente, N.
Right arrow Articles by Cate, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by di Clemente, N.
Right arrow Articles by Cate, R.

Molecular Endocrinology, Vol 8, 1006-1020, Copyright © 1994 by Endocrine Society

ARTICLES

Cloning, expression, and alternative splicing of the receptor for anti- Mullerian hormone

N di Clemente, C Wilson, E Faure, L Boussin, P Carmillo, R Tizard, JY Picard, B Vigier, N Josso and R Cate
Unite de Recherches sur l'Endocrinologie du Developpement, (INSERM), Departement de Biologie, Ecole Normale Superieure, Montrouge, France.

Anti-Mullerian hormone, also called Mullerian-inhibiting substance or factor, is a glycoprotein dimer belonging to the transforming growth factor-beta superfamily and synthesized by immature Sertoli cells and postnatal granulosa cells. Anti-Mullerian hormone plays a key role in sex differentiation by inducing the regression of Mullerian ducts in the male fetus. It is also responsible for the stunting and masculinization of fetal ovaries in bovine freemartin fetuses and may be involved in the control of follicular maturation in the postnatal ovary. Using a degenerate probe for a consensus region of the transforming growth factor-beta receptor superfamily to screen a complementary DNA library from rabbit fetal ovaries, we cloned a complementary DNA coding for a transmembrane serine/threonine kinase, which is expressed around the fetal Mullerian duct, in fetal and adult granulosa cells, and in immature Sertoli cells. Two transcripts, generated by alternative splicing of an exon coding for an N-terminal 61-amino acid domain, are strongly expressed in anti-Mullerian hormone target organs and Sertoli cells. The longer, 569-amino acid, isoform binds anti-Mullerian hormone when transiently expressed in COS cells and is believed to encode its functional receptor.


This article has been cited by other articles:


Home page
 J AndrolHome page
X. Wu, S. Wan, S. Pujar, M. E. Haskins, D. H. Schlafer, M. M. Lee, and V. N. Meyers-Wallen
A Single Base Pair Mutation Encoding a Premature Stop Codon in the MIS Type II Receptor Is Responsible for Canine Persistent Mullerian Duct Syndrome
J Androl, January 1, 2009; 30(1): 46 - 56.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. E. Kevenaar, J. S. E. Laven, S. L. Fong, A. G. Uitterlinden, F. H. de Jong, A. P. N. Themmen, and J. A. Visser
A Functional Anti-Mullerian Hormone Gene Polymorphism Is Associated with Follicle Number and Androgen Levels in Polycystic Ovary Syndrome Patients
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1310 - 1316.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. Shiraishi, N. Yoshinaga, T. Miura, H. Yokoi, Y. Wakamatsu, S.-I. Abe, and T. Kitano
Mullerian Inhibiting Substance Is Required for Germ Cell Proliferation during Early Gonadal Differentiation in Medaka (Oryzias latipes)
Endocrinology, April 1, 2008; 149(4): 1813 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Klattig, R. Sierig, D. Kruspe, B. Besenbeck, and C. Englert
Wilms' Tumor Protein Wt1 Is an Activator of the Anti-Mullerian Hormone Receptor Gene Amhr2
Mol. Cell. Biol., June 15, 2007; 27(12): 4355 - 4364.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Pieretti-Vanmarcke, P. K. Donahoe, L. A. Pearsall, D. M. Dinulescu, D. C. Connolly, E. F. Halpern, M. V. Seiden, and D. T. MacLaughlin
Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer
PNAS, November 14, 2006; 103(46): 17426 - 17431.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. T. Tran, D. L. Segev, V. Gupta, H. Kawakubo, G. Yeo, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Regulates Androgen-Induced Gene Expression and Growth in Prostate Cancer Cells through a Nuclear Factor-{kappa}B-Dependent Smad-Independent Mechanism
Mol. Endocrinol., October 1, 2006; 20(10): 2382 - 2391.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
S J. Lin, T. F Lerch, R. W Cook, T. S Jardetzky, and T. K Woodruff
The structural basis of TGF-{beta}, bone morphogenetic protein, and activin ligand binding.
Reproduction, August 1, 2006; 132(2): 179 - 190.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
C. Itman, S. Mendis, B. Barakat, and K. L. Loveland
All in the family: TGF-{beta} family action in testis development.
Reproduction, August 1, 2006; 132(2): 233 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Q.-a. Yuan, H. H. Simmons, M. K. Robinson, M. Russeva, W. A. Marasco, and G. P. Adams
Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer.
Mol. Cancer Ther., August 1, 2006; 5(8): 2096 - 2105.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
S. Mazerbourg and A. J.W. Hsueh
Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands
Hum. Reprod. Update, July 1, 2006; 12(4): 373 - 383.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
Y. Zhan, A. Fujino, D. T. MacLaughlin, T. F. Manganaro, P. P. Szotek, N. A. Arango, J. Teixeira, and P. K. Donahoe
Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression
Development, June 15, 2006; 133(12): 2359 - 2369.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Endocr. Rev., April 1, 2006; 27(2): 170 - 207.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Pieretti-Vanmarcke, P. K. Donahoe, P. Szotek, T. Manganaro, M. K. Lorenzen, J. Lorenzen, D. C. Connolly, E. F. Halpern, and D. T. MacLaughlin
Recombinant Human Mullerian Inhibiting Substance Inhibits Long-term Growth of MIS Type II Receptor-Directed Transgenic Mouse Ovarian Cancers In vivo
Clin. Cancer Res., March 1, 2006; 12(5): 1593 - 1598.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P.-Y. Wang, K. Koishi, A. B. McGeachie, M. Kimber, D. T. MacLaughlin, P. K. Donahoe, and I. S. McLennan
Mullerian Inhibiting Substance acts as a motor neuron survival factor in vitro
PNAS, November 8, 2005; 102(45): 16421 - 16425.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Mazerbourg, K. Sangkuhl, C.-W. Luo, S. Sudo, C. Klein, and A. J. W. Hsueh
Identification of Receptors and Signaling Pathways for Orphan Bone Morphogenetic Protein/Growth Differentiation Factor Ligands Based on Genomic Analyses
J. Biol. Chem., September 16, 2005; 280(37): 32122 - 32132.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
N. Josso, C. Belville, N. di Clemente, and J.-Y. Picard
AMH and AMH receptor defects in persistent Mullerian duct syndrome
Hum. Reprod. Update, July 1, 2005; 11(4): 351 - 356.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
Y. Yin and L. Ma
Development of the Mammalian Female Reproductive Tract
J. Biochem., June 1, 2005; 137(6): 677 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Gupta, J. L. Carey, H. Kawakubo, A. Muzikansky, J. E. Green, P. K. Donahoe, D. T. MacLaughlin, and S. Maheswaran
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model
PNAS, March 1, 2005; 102(9): 3219 - 3224.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. J. Renaud, D. T. MacLaughlin, E. Oliva, B. R. Rueda, and P. K. Donahoe
Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance
PNAS, January 4, 2005; 102(1): 111 - 116.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. La Marca, S. Malmusi, S. Giulini, L. F. Tamaro, R. Orvieto, P. Levratti, and A. Volpe
Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation
Hum. Reprod., December 1, 2004; 19(12): 2738 - 2741.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. J. Jorgez, M. Klysik, S. P. Jamin, R. R. Behringer, and M. M. Matzuk
Granulosa Cell-Specific Inactivation of Follistatin Causes Female Fertility Defects
Mol. Endocrinol., April 1, 2004; 18(4): 953 - 967.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. Belville, H. Van Vlijmen, C. Ehrenfels, B. Pepinsky, A. R. Rezaie, J.-Y. Picard, N. Josso, N. d. Clemente, and R. L. Cate
Mutations of the Anti-Mullerian Hormone Gene in Patients with Persistent Mullerian Duct Syndrome: Biosynthesis, Secretion, and Processing of the Abnormal Proteins and Analysis Using a Three-Dimensional Model
Mol. Endocrinol., March 1, 2004; 18(3): 708 - 721.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. Shimasaki, R. K. Moore, F. Otsuka, and G. F. Erickson
The Bone Morphogenetic Protein System In Mammalian Reproduction
Endocr. Rev., February 1, 2004; 25(1): 72 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A. J. Pask, D. J. Whitworth, C.-A. Mao, K.-J. Wei, N. Sankovic, J. A. M. Graves, G. Shaw, M. B. Renfree, and R. R. Behringer
Marsupial Anti-Mullerian Hormone Gene Structure, Regulatory Elements, and Expression
Biol Reprod, January 1, 2004; 70(1): 160 - 167.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Y. Bedecarrats, F. H. O'Neill, E. R. Norwitz, U. B. Kaiser, and J. Teixeira
Regulation of gonadotropin gene expression by Mullerian inhibiting substance
PNAS, August 5, 2003; 100(16): 9348 - 9353.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Hossain and G. F. Saunders
Synergistic Cooperation between the {beta}-Catenin Signaling Pathway and Steroidogenic Factor 1 in the Activation of the Mullerian Inhibiting Substance Type II Receptor
J. Biol. Chem., July 11, 2003; 278(29): 26511 - 26516.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. Lukas-Croisier, C. Lasala, J. Nicaud, P. Bedecarras, T. R. Kumar, M. Dutertre, M. M. Matzuk, J.-Y. Picard, N. Josso, and R. Rey
Follicle-Stimulating Hormone Increases Testicular Anti-Mullerian Hormone (AMH) Production through Sertoli Cell Proliferation and a Nonclassical Cyclic Adenosine 5'-Monophosphate-Mediated Activation of the AMH Gene
Mol. Endocrinol., April 1, 2003; 17(4): 550 - 561.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. C. Connolly, R. Bao, A. Y. Nikitin, K. C. Stephens, T. W. Poole, X. Hua, S. S. Harris, B. C. Vanderhyden, and T. C. Hamilton
Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer
Cancer Res., March 15, 2003; 63(6): 1389 - 1397.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation
Endocrinology, September 1, 2002; 143(9): 3351 - 3360.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Teixeira, S. Maheswaran, and P. K. Donahoe
Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications
Endocr. Rev., October 1, 2001; 22(5): 657 - 674.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Messika-Zeitoun, L. Gouedard, C. Belville, M. Dutertre, L. Lins, S. Imbeaud, I. A. Hughes, J.-Y. Picard, N. Josso, and N. di Clemente
Autosomal Recessive Segregation of a Truncating Mutation of Anti-Mullerian Type II Receptor in a Family Affected by the Persistent Mullerian Duct Syndrome Contrasts with Its Dominant Negative Activity in Vitro
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4390 - 4397.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Dutertre, L. Gouedard, F. Xavier, W.-Q. Long, N. di Clemente, J.-Y. Picard, and R. Rey
Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Mullerian Hormone in Transgenic Mice
Endocrinology, September 1, 2001; 142(9): 4040 - 4046.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. A. Visser, R. Olaso, M. Verhoef-Post, P. Kramer, A. P. N. Themmen, and H. A. Ingraham
The Serine/Threonine Transmembrane Receptor ALK2 Mediates Mullerian Inhibiting Substance Signaling
Mol. Endocrinol., June 1, 2001; 15(6): 936 - 945.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. R. Clarke, Y. Hoshiya, S. E. Yi, X. Liu, K. M. Lyons, and P. K. Donahoe
Mullerian Inhibiting Substance Signaling Uses a Bone Morphogenetic Protein (BMP)-Like Pathway Mediated by ALK2 and Induces Smad6 Expression
Mol. Endocrinol., June 1, 2001; 15(6): 946 - 959.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. T. MacLaughlin, J. Teixeira, and P. K. Donahoe
Perspective: Reproductive Tract Development--New Discoveries and Future Directions
Endocrinology, June 1, 2001; 142(6): 2167 - 2172.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. E. Stephen, P. T. Masiakos, D. L. Segev, J. P. Vacanti, P. K. Donahoe, and D. T. MacLaughlin
Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo
PNAS, February 22, 2001; (2001) 51625998.
[Abstract] [Full Text]

Home page
 Genes Dev.Home page
S. Nef and L. F. Parada
Hormones in male sexual development
Genes & Dev., December 15, 2000; 14(24): 3075 - 3086.
[Full Text]

Home page
 DevelopmentHome page
S Allard, P Adin, L Gouedard, N di Clemente, N Josso, M. Orgebin-Crist, J. Picard, and F Xavier
Molecular mechanisms of hormone-mediated Mullerian duct regression: involvement of beta-catenin
Development, January 8, 2000; 127(15): 3349 - 3360.
[Abstract] [PDF]

Home page
 Am. J. Pathol.Home page
J. George, S.-S. Wang, A.-M. Sevcsik, M. Sanicola, R. L. Cate, V. E. Koteliansky, and D. M. Bissell
Transforming Growth Factor-{beta} Initiates Wound Repair in Rat Liver through Induction of the EIIIA-Fibronectin Splice Isoform
Am. J. Pathol., January 1, 2000; 156(1): 115 - 124.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. L. L. Durlinger, P. Kramer, B. Karels, F. H. de Jong, J. Th. J. Uilenbroek, J. A. Grootegoed, and A. P. N. Themmen
Control of Primordial Follicle Recruitment by Anti-Mullerian Hormone in the Mouse Ovary
Endocrinology, December 1, 1999; 140(12): 5789 - 5796.
[Abstract] [Full Text]

Home page
 FASEB J.Home page
E. PIEK, C.-H. HELDIN, and P. TEN DIJKE
Specificity, diversity, and regulation in TGF-{beta} superfamily signaling
FASEB J, December 1, 1999; 13(15): 2105 - 2124.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Teixeira, D. J. Kehas, R. Antun, and P. K. Donahoe
Transcriptional regulation of the rat Mullerian inhibiting substance type II receptor in rodent Leydig cells
PNAS, November 23, 1999; 96(24): 13831 - 13838.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. T. Masiakos, D. T. MacLaughlin, S. Maheswaran, J. Teixeira, A. F. Fuller Jr., P. C. Shah, D. J. Kehas, M. K. Kenneally, D. M. Dombkowski, T. U. Ha, et al.
Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS
Clin. Cancer Res., November 1, 1999; 5(11): 3488 - 3499.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. George, D. Roulot, V. E. Koteliansky, and D. M. Bissell
In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis
PNAS, October 26, 1999; 96(22): 12719 - 12724.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Teixeira, E. Fynn-Thompson, A. H. Payne, and P. K. Donahoe
Mullerian-Inhibiting Substance Regulates Androgen Synthesis at the Transcriptional Level
Endocrinology, October 1, 1999; 140(10): 4732 - 4738.
[Abstract] [Full Text]

Home page
 ThoraxHome page
Q. Wang, Y. Wang, D. M Hyde, P. J Gotwals, V. E Koteliansky, S. T Ryan, and S. N Giri
Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters
Thorax, September 1, 1999; 54(9): 805 - 812.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
M. M. Lee, C. C. Seah, P. T. Masiakos, C. M. Sottas, F. I. Preffer, P. K. Donahoe, D. T. MacLaughlin, and M. P. Hardy
Mullerian-Inhibiting Substance Type II Receptor Expression and Function in Purified Rat Leydig Cells
Endocrinology, June 1, 1999; 140(6): 2819 - 2827.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
J. D. Smith, S. R. Bryant, L. L. Couper, C. P. H. Vary, P. J. Gotwals, V. E. Koteliansky, and V. Lindner
Soluble Transforming Growth Factor-ß Type II Receptor Inhibits Negative Remodeling, Fibroblast Transdifferentiation, and Intimal Lesion Formation But Not Endothelial Growth
Circ. Res., May 28, 1999; 84(10): 1212 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Mishina, D. J. Whitworth, C. Racine, and R. R. Behringer
High Specificity of Mullerian-Inhibiting Substance Signaling in Vivo
Endocrinology, May 1, 1999; 140(5): 2084 - 2088.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
P. d. S. Barbara, B. Moniot, F. Poulat, B. Boizet, and P. Berta
Steroidogenic Factor-1 Regulates Transcription of the Human Anti-mullerian Hormone Receptor
J. Biol. Chem., November 6, 1998; 273(45): 29654 - 29660.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. A. Visser, A. McLuskey, M. Verhoef-Post, P. Kramer, J. A. Grootegoed, and A. P. N. Themmen
Effect of Prenatal Exposure to Diethylstilbestrol on Mullerian Duct Development in Fetal Male Mice
Endocrinology, October 1, 1998; 139(10): 4244 - 4251.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. Rouiller-Fabre, S. Carmona, R. A. Merhi, R. Cate, R. Habert, and B. Vigier
Effect of Anti-Mullerian Hormone on Sertoli and Leydig Cell Functions in Fetal and Immature Rats
Endocrinology, March 1, 1998; 139(3): 1213 - 1220.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Racine, R. Rey, M. G. Forest, F. Louis, A. Ferre, I. Huhtaniemi, N. Josso, and N. di Clemente
Receptors for anti-Mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation
PNAS, January 20, 1998; 95(2): 594 - 599.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
C. M. HAQQ and P. K. DONAHOE
Regulation of Sexual Dimorphism in Mammals
Physiol Rev, January 1, 1998; 78(1): 1 - 33.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. A. Catlin, V. C. Tonnu, R. G. Ebb, B. A. Pacheco, T. F. Manganaro, R. M. Ezzell, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance Inhibits Branching Morphogenesis and Induces Apoptosis in Fetal Rat Lung
Endocrinology, February 1, 1997; 138(2): 790 - 796.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
G Giuili, W. Shen, and H. Ingraham
The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian Inhibiting Substance, in vivo
Development, January 5, 1997; 124(9): 1799 - 1807.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
E. Faure, L. Gouedard, S. Imbeaud, R. Cate, J.-Y. Picard, N. Josso, and N. di Clemente
Mutant Isoforms of the Anti-Mullerian Hormone Type II Receptor Are Not Expressed at the Cell Membrane
J. Biol. Chem., November 29, 1996; 271(48): 30571 - 30575.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
Y Mishina, R Rey, M J Finegold, M M Matzuk, N Josso, R L Cate, and R R Behringer
Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation.
Genes & Dev., October 15, 1996; 10(20): 2577 - 2587.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
D.èl. C. Eusèbe, N. di Clemente, R. Rey, C. Pieau, B. Vigier, N. Josso, and J.-Y. Picard
Cloning and Expression of the Chick Anti-Müllerian Hormone Gene
J. Biol. Chem., March 1, 1996; 271(9): 4798 - 4804.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
D. Whitworth, G Shaw, and M. Renfree
Gonadal sex reversal of the developing marsupial ovary in vivo and in vitro
Development, January 12, 1996; 122(12): 4057 - 4063.
[Abstract] [PDF]

Home page
 Genes Dev.Home page
Y Mishina, A Suzuki, N Ueno, and R R Behringer
Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis.
Genes & Dev., December 15, 1995; 9(24): 3027 - 3037.
[Abstract] [PDF]